| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | small conductance calcium-activated potassium channel activity | 4.29e-05 | 4 | 54 | 2 | GO:0016286 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.88e-04 | 891 | 54 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | calcium-activated potassium channel activity | 6.40e-04 | 14 | 54 | 2 | GO:0015269 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 6.31e-06 | 46 | 54 | 4 | GO:0010526 | |
| GeneOntologyBiologicalProcess | retrotransposition | 7.49e-06 | 48 | 54 | 4 | GO:0032197 | |
| GeneOntologyBiologicalProcess | transposition | 8.84e-06 | 50 | 54 | 4 | GO:0032196 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 ZNF684 EGR1 EGR4 ZNF728 TUT7 ZBTB10 ZNF91 ZNF593 ZNF99 ZNF804A | 7.63e-06 | 777 | 52 | 11 | PS00028 |
| Domain | Znf_C2H2 | ZNF729 ZNF684 EGR1 EGR4 ZNF728 TUT7 ZBTB10 ZNF91 ZNF593 ZNF99 ZNF804A | 1.07e-05 | 805 | 52 | 11 | IPR007087 |
| Domain | CaM-bd_dom | 4.55e-05 | 4 | 52 | 2 | IPR004178 | |
| Domain | CaMBD | 4.55e-05 | 4 | 52 | 2 | SM01053 | |
| Domain | SK_channel | 4.55e-05 | 4 | 52 | 2 | PF03530 | |
| Domain | CaMBD | 4.55e-05 | 4 | 52 | 2 | PF02888 | |
| Domain | K_chnl_Ca-activ_SK | 4.55e-05 | 4 | 52 | 2 | IPR015449 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 ZNF684 EGR1 EGR4 ZNF728 ZBTB10 ZNF91 ZNF593 ZNF99 ZNF804A | 4.64e-05 | 775 | 52 | 10 | PS50157 |
| Domain | Znf_C2H2-like | ZNF729 ZNF684 EGR1 EGR4 ZNF728 ZBTB10 ZNF91 ZNF593 ZNF99 ZNF804A | 5.81e-05 | 796 | 52 | 10 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF729 ZNF684 EGR1 EGR4 ZNF728 ZBTB10 ZNF91 ZNF593 ZNF99 ZNF804A | 6.59e-05 | 808 | 52 | 10 | SM00355 |
| Domain | - | 5.35e-04 | 679 | 52 | 8 | 3.30.160.60 | |
| Domain | zf-C2H2 | 6.12e-04 | 693 | 52 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 6.18e-04 | 694 | 52 | 8 | IPR013087 | |
| Domain | K_chnl_dom | 1.54e-03 | 21 | 52 | 2 | IPR013099 | |
| Domain | Ion_trans_2 | 1.54e-03 | 21 | 52 | 2 | PF07885 | |
| Domain | zf-C2H2_jaz | 1.69e-03 | 22 | 52 | 2 | PF12171 | |
| Domain | Znf_C2H2_jaz | 1.69e-03 | 22 | 52 | 2 | IPR022755 | |
| Domain | zf-C2H2_6 | 1.77e-03 | 314 | 52 | 5 | PF13912 | |
| Domain | zf-CCHC | 1.85e-03 | 23 | 52 | 2 | PF00098 | |
| Domain | - | 2.37e-03 | 26 | 52 | 2 | 4.10.60.10 | |
| Domain | ZnF_U1 | 2.94e-03 | 29 | 52 | 2 | SM00451 | |
| Domain | Znf_U1 | 2.94e-03 | 29 | 52 | 2 | IPR003604 | |
| Domain | KRAB | 3.13e-03 | 358 | 52 | 5 | PS50805 | |
| Domain | KRAB | 3.13e-03 | 358 | 52 | 5 | PF01352 | |
| Domain | KRAB | 3.56e-03 | 369 | 52 | 5 | SM00349 | |
| Domain | KRAB | 3.60e-03 | 370 | 52 | 5 | IPR001909 | |
| Domain | ZF_CCHC | 4.27e-03 | 35 | 52 | 2 | PS50158 | |
| Domain | SET | 5.82e-03 | 41 | 52 | 2 | PF00856 | |
| Domain | SET | 7.28e-03 | 46 | 52 | 2 | SM00317 | |
| Domain | SET_dom | 8.55e-03 | 50 | 52 | 2 | IPR001214 | |
| Domain | SET | 8.55e-03 | 50 | 52 | 2 | PS50280 | |
| Pubmed | FAM133B WDR3 GNL3L RBBP6 HMGXB4 XRN1 RCN2 AATF PRPF38B CHD1 GPATCH4 RSRC2 ZNF593 EZH2 AGAP1 | 7.05e-09 | 1497 | 55 | 15 | 31527615 | |
| Pubmed | GNL3L TRIO TUT7 XRN1 RCN2 FIP1L1 CHD1 ZDBF2 RSRC2 NEDD1 RPL19 | 1.74e-08 | 733 | 55 | 11 | 34672954 | |
| Pubmed | WDR3 GNL3L RBBP6 ZBTB10 FIP1L1 AATF CHD1 GPATCH4 SRRM2 PRPF40A RPL19 | 7.55e-08 | 847 | 55 | 11 | 35850772 | |
| Pubmed | GNL3L RBBP6 HMGXB4 ASH1L XRN1 ZBTB10 RCN2 FIP1L1 GPATCH4 RSRC2 SRRM2 PRPF40A | 1.38e-07 | 1116 | 55 | 12 | 31753913 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FAM133B WDR3 GNL3L RBBP6 FIP1L1 AATF GPATCH4 ZNF593 SRRM2 PRPF40A RPL19 | 2.35e-07 | 949 | 55 | 11 | 36574265 |
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 4.46e-07 | 10 | 55 | 3 | 18588511 | |
| Pubmed | 4.93e-07 | 808 | 55 | 10 | 20412781 | ||
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 6.12e-07 | 11 | 55 | 3 | 15469996 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 19850934 | ||
| Pubmed | 1.68e-06 | 15 | 55 | 3 | 15885501 | ||
| Pubmed | 1.87e-06 | 723 | 55 | 9 | 34133714 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.02e-06 | 130 | 55 | 5 | 35545047 | |
| Pubmed | 2.04e-06 | 731 | 55 | 9 | 29298432 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WDR3 RBBP6 HMGXB4 FIP1L1 AATF CHD1 GPATCH4 ZDBF2 SRRM2 PRPF40A | 2.20e-06 | 954 | 55 | 10 | 36373674 |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 11395478 | ||
| Pubmed | Suppression of Ca2+ signals by EGR4 controls Th1 differentiation and anti-cancer immunity in vivo. | 2.46e-06 | 2 | 55 | 2 | 32212315 | |
| Pubmed | A novel isoform of SK2 assembles with other SK subunits in mouse brain. | 2.46e-06 | 2 | 55 | 2 | 15797870 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 12778407 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 30922569 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 33009487 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 10866682 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 27874831 | ||
| Pubmed | Gene expression analysis in absence epilepsy using a monozygotic twin design. | 2.46e-06 | 2 | 55 | 2 | 18435749 | |
| Pubmed | SK2 and SK3 expression differentially affect firing frequency and precision in dopamine neurons. | 2.46e-06 | 2 | 55 | 2 | 22554781 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 23129791 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25605734 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 10988076 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 36502918 | ||
| Pubmed | 4.23e-06 | 68 | 55 | 4 | 22779921 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.56e-06 | 807 | 55 | 9 | 22681889 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.75e-06 | 605 | 55 | 8 | 28977666 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | WDR3 USP42 RBBP6 HMGXB4 FIP1L1 AATF GPATCH4 EZH2 SRRM2 PRPF40A RPL19 | 4.82e-06 | 1294 | 55 | 11 | 30804502 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FAM133B WDR3 USP42 RBBP6 AATF PRPF38B CHD1 GPATCH4 SRRM2 PRPF40A RPL19 | 5.73e-06 | 1318 | 55 | 11 | 30463901 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | USP42 RBBP6 HMGXB4 RCN2 FIP1L1 PRPF38B RSRC2 ZNF593 SRRM2 PRPF40A | 6.68e-06 | 1082 | 55 | 10 | 38697112 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | WDR3 GNL3L TUT7 XRN1 ZBTB10 FIP1L1 AATF CHD1 GPATCH4 SRRM2 RPL19 | 7.35e-06 | 1353 | 55 | 11 | 29467282 |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 15234350 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 20689065 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 11557517 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 11146124 | ||
| Pubmed | Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons. | 7.36e-06 | 3 | 55 | 2 | 24434522 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 16055520 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 22416006 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 33310041 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 12382077 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 15190101 | ||
| Pubmed | 8.28e-06 | 653 | 55 | 8 | 22586326 | ||
| Pubmed | 1.33e-05 | 29 | 55 | 3 | 14563677 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.37e-05 | 330 | 55 | 6 | 33301849 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.47e-05 | 934 | 55 | 9 | 33916271 | |
| Pubmed | An amphioxus Krox gene: insights into vertebrate hindbrain evolution. | 1.47e-05 | 4 | 55 | 2 | 11180801 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 11891986 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 12882916 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 30593723 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 29737974 | ||
| Pubmed | 1.56e-05 | 713 | 55 | 8 | 29802200 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.64e-05 | 341 | 55 | 6 | 32971831 | |
| Pubmed | 1.90e-05 | 206 | 55 | 5 | 34185411 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.05e-05 | 533 | 55 | 7 | 30554943 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.27e-05 | 361 | 55 | 6 | 26167880 | |
| Pubmed | RBBP6 XRN1 RCN2 FIP1L1 PRPF38B GPATCH4 RSRC2 SRRM2 PRPF40A RPL19 | 2.28e-05 | 1247 | 55 | 10 | 27684187 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.30e-05 | 989 | 55 | 9 | 36424410 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.44e-05 | 759 | 55 | 8 | 35915203 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 26360614 | ||
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 12560487 | ||
| Pubmed | No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. | 3.67e-05 | 6 | 55 | 2 | 20144677 | |
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 3.76e-05 | 118 | 55 | 4 | 37105989 | |
| Pubmed | 4.88e-05 | 251 | 55 | 5 | 31076518 | ||
| Pubmed | WDR3 GNL3L TUT7 RCN2 FIP1L1 AATF PRPF38B GPATCH4 RSRC2 PRPF40A | 5.09e-05 | 1371 | 55 | 10 | 36244648 | |
| Pubmed | Synaptic, transcriptional and chromatin genes disrupted in autism. | 5.13e-05 | 7 | 55 | 2 | 25363760 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 5.57e-05 | 853 | 55 | 8 | 28718761 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 6.55e-05 | 49 | 55 | 3 | 9630514 | |
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 16382103 | ||
| Pubmed | RBBP6 HMGXB4 XRN1 ZBTB10 RCN2 FIP1L1 GPATCH4 SRRM2 PRPF40A RPL19 | 7.19e-05 | 1429 | 55 | 10 | 35140242 | |
| Pubmed | 7.54e-05 | 655 | 55 | 7 | 35819319 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 9.35e-05 | 678 | 55 | 7 | 30209976 | |
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 22895009 | ||
| Pubmed | 1.13e-04 | 300 | 55 | 5 | 28561026 | ||
| Pubmed | 1.84e-04 | 1297 | 55 | 9 | 33545068 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 1.89e-04 | 13 | 55 | 2 | 21173153 | |
| Pubmed | 1.89e-04 | 13 | 55 | 2 | 18172165 | ||
| Pubmed | 1.89e-04 | 13 | 55 | 2 | 23948251 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.11e-04 | 774 | 55 | 7 | 15302935 | |
| Pubmed | 2.21e-04 | 14 | 55 | 2 | 10758170 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.28e-04 | 349 | 55 | 5 | 25665578 | |
| Pubmed | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. | 2.31e-04 | 350 | 55 | 5 | 26549023 | |
| Pubmed | 2.90e-04 | 16 | 55 | 2 | 8467795 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 3.37e-04 | 85 | 55 | 3 | 16051665 | |
| Pubmed | 3.46e-04 | 210 | 55 | 4 | 16565220 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 3.67e-04 | 1124 | 55 | 8 | 21900206 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 3.68e-04 | 1425 | 55 | 9 | 30948266 | |
| Pubmed | 3.70e-04 | 18 | 55 | 2 | 9858769 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.90e-04 | 608 | 55 | 6 | 36089195 | |
| Pubmed | Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. | 4.13e-04 | 19 | 55 | 2 | 30385546 | |
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 4.13e-04 | 19 | 55 | 2 | 22144910 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.76e-04 | 410 | 55 | 5 | 26949251 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 5.59e-04 | 101 | 55 | 3 | 24613305 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 5.75e-04 | 1203 | 55 | 8 | 29180619 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 6.03e-04 | 922 | 55 | 7 | 27609421 | |
| Pubmed | 6.09e-04 | 104 | 55 | 3 | 31365120 | ||
| Pubmed | 6.43e-04 | 106 | 55 | 3 | 12429849 | ||
| Interaction | ZCCHC10 interactions | 1.30e-07 | 236 | 51 | 8 | int:ZCCHC10 | |
| Interaction | MYCN interactions | FAM133B WDR3 GNL3L RBBP6 TUT7 HMGXB4 RCN2 FIP1L1 AATF PRPF38B GPATCH4 ZNF593 EZH2 SRRM2 PRPF40A RPL19 | 1.45e-07 | 1373 | 51 | 16 | int:MYCN |
| Interaction | MAGEB2 interactions | 2.03e-07 | 349 | 51 | 9 | int:MAGEB2 | |
| Interaction | CEP192 interactions | 5.19e-07 | 192 | 51 | 7 | int:CEP192 | |
| Interaction | DHX8 interactions | 6.55e-07 | 292 | 51 | 8 | int:DHX8 | |
| Interaction | SRPK2 interactions | RBBP6 HMGXB4 KCNN2 FIP1L1 AATF PRPF38B GPATCH4 RSRC2 ZNF593 SRRM2 PRPF40A | 1.39e-06 | 717 | 51 | 11 | int:SRPK2 |
| Interaction | DHX40 interactions | 2.94e-06 | 249 | 51 | 7 | int:DHX40 | |
| Interaction | NUP43 interactions | 3.11e-06 | 625 | 51 | 10 | int:NUP43 | |
| Interaction | BRD3 interactions | 3.62e-06 | 494 | 51 | 9 | int:BRD3 | |
| Interaction | SNRNP40 interactions | WDR3 USP42 RBBP6 AATF CHD1 GPATCH4 ZDBF2 SAGE1 SRRM2 PRPF40A | 3.68e-06 | 637 | 51 | 10 | int:SNRNP40 |
| Interaction | MEN1 interactions | WDR3 GNL3L RBBP6 ZBTB10 FIP1L1 AATF CHD1 GPATCH4 EZH2 SRRM2 PRPF40A RPL19 | 7.36e-06 | 1029 | 51 | 12 | int:MEN1 |
| Interaction | TERF2IP interactions | 8.87e-06 | 552 | 51 | 9 | int:TERF2IP | |
| Interaction | SPP1 interactions | 1.01e-05 | 114 | 51 | 5 | int:SPP1 | |
| Interaction | JMJD6 interactions | 1.27e-05 | 205 | 51 | 6 | int:JMJD6 | |
| Interaction | DDX23 interactions | 2.53e-05 | 480 | 51 | 8 | int:DDX23 | |
| Interaction | DOT1L interactions | WDR3 GNL3L RBBP6 FIP1L1 AATF CHD1 GPATCH4 SRRM2 PRPF40A RPL19 | 2.88e-05 | 807 | 51 | 10 | int:DOT1L |
| Interaction | POLR1G interactions | 2.89e-05 | 489 | 51 | 8 | int:POLR1G | |
| Interaction | CBX3 interactions | 3.08e-05 | 646 | 51 | 9 | int:CBX3 | |
| Interaction | CIT interactions | WDR3 RBBP6 ASH1L RCN2 FIP1L1 AATF PRPF38B CHD1 GPATCH4 EZH2 SRRM2 PRPF40A RPL19 | 4.72e-05 | 1450 | 51 | 13 | int:CIT |
| Interaction | ZC3H18 interactions | WDR3 RBBP6 FIP1L1 PRPF38B GPATCH4 RSRC2 EZH2 SRRM2 PRPF40A RPL19 | 5.83e-05 | 877 | 51 | 10 | int:ZC3H18 |
| Interaction | RPL35A interactions | 6.79e-05 | 405 | 51 | 7 | int:RPL35A | |
| Interaction | POP1 interactions | 6.85e-05 | 277 | 51 | 6 | int:POP1 | |
| Interaction | OBSL1 interactions | 7.37e-05 | 902 | 51 | 10 | int:OBSL1 | |
| Interaction | NOP56 interactions | 8.50e-05 | 570 | 51 | 8 | int:NOP56 | |
| Interaction | RNPS1 interactions | 9.18e-05 | 425 | 51 | 7 | int:RNPS1 | |
| Interaction | SURF6 interactions | 9.31e-05 | 426 | 51 | 7 | int:SURF6 | |
| Interaction | ADA2 interactions | 9.36e-05 | 6 | 51 | 2 | int:ADA2 | |
| Interaction | NIFK interactions | 1.00e-04 | 431 | 51 | 7 | int:NIFK | |
| Interaction | CHD4 interactions | WDR3 GNL3L RBBP6 HMGXB4 XRN1 FIP1L1 EZH2 SRRM2 PRPF40A RPL19 | 1.02e-04 | 938 | 51 | 10 | int:CHD4 |
| Interaction | PHIP interactions | 1.38e-04 | 197 | 51 | 5 | int:PHIP | |
| Interaction | RAD18 interactions | 1.44e-04 | 457 | 51 | 7 | int:RAD18 | |
| Interaction | HECTD1 interactions | FAM133B WDR3 RBBP6 TUT7 XRN1 AATF PRPF38B GPATCH4 PRPF40A RPL19 | 1.51e-04 | 984 | 51 | 10 | int:HECTD1 |
| Interaction | SRRM2 interactions | 1.54e-04 | 462 | 51 | 7 | int:SRRM2 | |
| Interaction | SMC5 interactions | WDR3 RBBP6 HMGXB4 FIP1L1 AATF CHD1 GPATCH4 ZDBF2 SRRM2 PRPF40A | 1.73e-04 | 1000 | 51 | 10 | int:SMC5 |
| Interaction | FBL interactions | 1.87e-04 | 639 | 51 | 8 | int:FBL | |
| Interaction | RPS19 interactions | 1.87e-04 | 639 | 51 | 8 | int:RPS19 | |
| Interaction | TNIP1 interactions | FAM133B WDR3 GNL3L RBBP6 FIP1L1 AATF GPATCH4 ZNF593 SRRM2 PRPF40A RPL19 | 1.89e-04 | 1217 | 51 | 11 | int:TNIP1 |
| Interaction | POLR1E interactions | 2.45e-04 | 350 | 51 | 6 | int:POLR1E | |
| Interaction | HDLBP interactions | 2.61e-04 | 855 | 51 | 9 | int:HDLBP | |
| Interaction | ZNF668 interactions | 2.62e-04 | 226 | 51 | 5 | int:ZNF668 | |
| Interaction | FOLR1 interactions | 2.67e-04 | 227 | 51 | 5 | int:FOLR1 | |
| Interaction | PYHIN1 interactions | 2.77e-04 | 358 | 51 | 6 | int:PYHIN1 | |
| Interaction | MECP2 interactions | USP42 RBBP6 HMGXB4 RCN2 FIP1L1 PRPF38B RSRC2 ZNF593 EZH2 SRRM2 PRPF40A | 3.08e-04 | 1287 | 51 | 11 | int:MECP2 |
| Interaction | U2AF1 interactions | 3.39e-04 | 239 | 51 | 5 | int:U2AF1 | |
| Interaction | IFI6 interactions | 3.46e-04 | 54 | 51 | 3 | int:IFI6 | |
| Interaction | RPL13 interactions | 3.46e-04 | 700 | 51 | 8 | int:RPL13 | |
| Interaction | DDX21 interactions | 4.10e-04 | 718 | 51 | 8 | int:DDX21 | |
| Interaction | CSTF3 interactions | 4.21e-04 | 139 | 51 | 4 | int:CSTF3 | |
| Interaction | RPL3 interactions | 4.25e-04 | 722 | 51 | 8 | int:RPL3 | |
| Interaction | CSNK1D interactions | 4.48e-04 | 254 | 51 | 5 | int:CSNK1D | |
| Interaction | CPSF1 interactions | 4.56e-04 | 255 | 51 | 5 | int:CPSF1 | |
| Interaction | ZNF512 interactions | 4.64e-04 | 256 | 51 | 5 | int:ZNF512 | |
| Interaction | PES1 interactions | 4.81e-04 | 258 | 51 | 5 | int:PES1 | |
| Interaction | NPM3 interactions | 5.15e-04 | 262 | 51 | 5 | int:NPM3 | |
| Interaction | SIRT7 interactions | 5.19e-04 | 744 | 51 | 8 | int:SIRT7 | |
| Interaction | HPS1 interactions | 5.60e-04 | 14 | 51 | 2 | int:HPS1 | |
| Interaction | CHD3 interactions | 5.81e-04 | 757 | 51 | 8 | int:CHD3 | |
| Interaction | IFI27L1 interactions | 5.97e-04 | 65 | 51 | 3 | int:IFI27L1 | |
| Interaction | NOP2 interactions | 6.13e-04 | 416 | 51 | 6 | int:NOP2 | |
| Interaction | RPL4 interactions | 6.18e-04 | 764 | 51 | 8 | int:RPL4 | |
| Interaction | SNIP1 interactions | 6.21e-04 | 417 | 51 | 6 | int:SNIP1 | |
| Interaction | FGF3 interactions | 6.24e-04 | 66 | 51 | 3 | int:FGF3 | |
| Interaction | USP42 interactions | 6.24e-04 | 66 | 51 | 3 | int:USP42 | |
| Interaction | NR2C2 interactions | FAM133B WDR3 USP42 RBBP6 AATF PRPF38B CHD1 GPATCH4 SRRM2 PRPF40A RPL19 | 6.40e-04 | 1403 | 51 | 11 | int:NR2C2 |
| Interaction | FTSJ3 interactions | 6.61e-04 | 422 | 51 | 6 | int:FTSJ3 | |
| Interaction | PRC1 interactions | 6.71e-04 | 973 | 51 | 9 | int:PRC1 | |
| Interaction | NAA40 interactions | 6.96e-04 | 978 | 51 | 9 | int:NAA40 | |
| Interaction | SNRNP70 interactions | 7.27e-04 | 984 | 51 | 9 | int:SNRNP70 | |
| Interaction | USP36 interactions | 7.36e-04 | 599 | 51 | 7 | int:USP36 | |
| Interaction | CNTROB interactions | 8.21e-04 | 166 | 51 | 4 | int:CNTROB | |
| Interaction | INO80B interactions | 8.39e-04 | 167 | 51 | 4 | int:INO80B | |
| Interaction | TRIR interactions | 8.72e-04 | 74 | 51 | 3 | int:TRIR | |
| Interaction | ZNF330 interactions | 8.81e-04 | 446 | 51 | 6 | int:ZNF330 | |
| Interaction | ZBTB2 interactions | 9.23e-04 | 450 | 51 | 6 | int:ZBTB2 | |
| Interaction | CPSF2 interactions | 9.57e-04 | 173 | 51 | 4 | int:CPSF2 | |
| Interaction | NINL interactions | 1.01e-03 | 458 | 51 | 6 | int:NINL | |
| Interaction | SAP18 interactions | 1.02e-03 | 305 | 51 | 5 | int:SAP18 | |
| Interaction | HNRNPC interactions | 1.03e-03 | 634 | 51 | 7 | int:HNRNPC | |
| Interaction | HNRNPU interactions | 1.04e-03 | 1035 | 51 | 9 | int:HNRNPU | |
| Cytoband | 19p12 | 4.36e-06 | 90 | 55 | 4 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.46e-05 | 122 | 55 | 4 | chr19p12 | |
| Cytoband | 1q22 | 2.16e-03 | 57 | 55 | 2 | 1q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q22 | 2.31e-03 | 59 | 55 | 2 | chr5q22 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.31e-05 | 718 | 34 | 8 | 28 | |
| GeneFamily | Potassium calcium-activated channels | 5.12e-05 | 6 | 34 | 2 | 255 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.85e-03 | 34 | 34 | 2 | 487 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.37e-02 | 95 | 34 | 2 | 59 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | ZNF729 ZRSR2P1 EGR1 PRPF38B CHD1 ZNF91 RSRC2 EZH2 ZNF99 PRPF40A | 8.62e-07 | 675 | 53 | 10 | MM1073 |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 5.21e-06 | 644 | 53 | 9 | M41717 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.96e-05 | 276 | 53 | 6 | M41128 | |
| Coexpression | TERAO_AOX4_TARGETS_SKIN_DN | 2.47e-05 | 28 | 53 | 3 | MM925 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | GNL3L TRIO TUT7 HMGXB4 XRN1 KCNN3 FIP1L1 NEDD1 ZNF804A AGAP1 | 2.96e-05 | 1009 | 53 | 10 | M157 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 4.76e-05 | 196 | 53 | 5 | MM667 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 8.77e-05 | 223 | 53 | 5 | M17621 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.20e-10 | 197 | 55 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-09 | 188 | 55 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-08 | 178 | 55 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 187 | 55 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.73e-07 | 200 | 55 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 182 | 55 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 183 | 55 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 183 | 55 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 4.13e-06 | 194 | 55 | 5 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 195 | 55 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.45e-06 | 197 | 55 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 4.45e-06 | 197 | 55 | 5 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.57e-06 | 198 | 55 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.57e-06 | 198 | 55 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.79e-06 | 200 | 55 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 154 | 55 | 4 | 874b1220337276489a89fcc9a39bc81ba6b68baf | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 165 | 55 | 4 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 165 | 55 | 4 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 7.68e-05 | 183 | 55 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 191 | 55 | 4 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 191 | 55 | 4 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 9.25e-05 | 192 | 55 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-05 | 192 | 55 | 4 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 193 | 55 | 4 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 9.43e-05 | 193 | 55 | 4 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 9.43e-05 | 193 | 55 | 4 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 194 | 55 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.04e-04 | 198 | 55 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.04e-04 | 198 | 55 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.06e-04 | 199 | 55 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 1.06e-04 | 199 | 55 | 4 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.07e-06 | 177 | 52 | 6 | 985_DN | |
| Drug | Succimer | EGR1 SNX24 RBBP6 ASH1L RCN2 FIP1L1 PRPF38B GPATCH4 RSRC2 DNAJC5B ZNF804A PRPF40A AGAP1 | 3.73e-06 | 1264 | 52 | 13 | ctd:D004113 |
| Drug | cyclohexyl-(2-(3,5-dimethylpyrazol-1-yl)-6-methylpyrimidin-4-yl)amine | 5.12e-06 | 2 | 52 | 2 | ctd:C552889 | |
| Drug | Magnetite Nanoparticles | EGR1 SNX24 RBBP6 ASH1L RCN2 FIP1L1 PRPF38B GPATCH4 RSRC2 DNAJC5B ZNF804A PRPF40A AGAP1 | 5.51e-06 | 1310 | 52 | 13 | ctd:D058185 |
| Drug | Apamin | 3.06e-05 | 4 | 52 | 2 | ctd:D001030 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.07e-04 | 17 | 52 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | response to venlafaxine | 8.90e-04 | 25 | 52 | 2 | EFO_0006328 | |
| Disease | internet addiction disorder | 1.55e-03 | 33 | 52 | 2 | EFO_0803368 | |
| Disease | diabetic retinopathy | 1.79e-03 | 136 | 52 | 3 | EFO_0003770 | |
| Disease | occupational attainment | 2.51e-03 | 42 | 52 | 2 | EFO_0020977 | |
| Disease | Paroxysmal atrial fibrillation | 2.65e-03 | 156 | 52 | 3 | C0235480 | |
| Disease | Persistent atrial fibrillation | 2.65e-03 | 156 | 52 | 3 | C2585653 | |
| Disease | familial atrial fibrillation | 2.65e-03 | 156 | 52 | 3 | C3468561 | |
| Disease | Atrial Fibrillation | 2.85e-03 | 160 | 52 | 3 | C0004238 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSSLKEKHKHKCKRR | 1241 | Q9NR48 | |
| RKSKHKLKKRRGHLS | 2316 | Q9NR48 | |
| RKKHRRKKSTSNFKA | 526 | Q9UPQ3 | |
| KKTYRKLALKHHPDK | 36 | Q9UF47 | |
| ESKRYGSKKKRHEKH | 141 | Q49A88 | |
| RKLHKLYKHAIKKRQ | 1491 | O14646 | |
| SFRKLHLKDKKRFEK | 146 | Q14257 | |
| RKKLHKFEETKKHFE | 376 | Q96PE3 | |
| LKSKRVHRSLKDHKD | 106 | Q8NHV4 | |
| KKIDHAKVRKHQRKF | 441 | Q9H2S1 | |
| RKRHTKIHLRQKDKK | 411 | P18146 | |
| HHRRKEIKSKKRKDK | 221 | Q70Z53 | |
| SLRKGKKKKRWHHEE | 286 | Q5T3I0 | |
| KKKRKHRLWAAHCRK | 491 | Q15910 | |
| TKLLKKIDHAKVRKH | 586 | Q9UGI6 | |
| RRHKHKKSKRSKEGK | 561 | Q6UN15 | |
| KKRHSKVHLKQKARA | 556 | Q05215 | |
| KEKHKEKRHSKSKRS | 331 | Q9UGU5 | |
| NKHKKHRKRRKGEES | 931 | Q7Z6E9 | |
| KKSKKHHRKRSRSRS | 816 | O75400 | |
| SEHKNRHSKDKKKTR | 226 | Q9P2N4 | |
| KASHALKKKILRFRS | 606 | Q96B18 | |
| RRKKKKNRSHKSSES | 131 | Q5BKY9 | |
| DLLKKKKHIRTRVHF | 766 | P0C221 | |
| KKRKTKHRHKFSEEL | 21 | A0A1W2PPK0 | |
| KRKTKHRHKFSEELL | 26 | A0A1W2PPM1 | |
| LYHAKKRISKKKTHV | 331 | Q9H2B2 | |
| RRHESKDKSSKKHKS | 71 | Q7L4I2 | |
| KKHRSESESKKRKHR | 216 | Q9UQ35 | |
| HFLTAVAHRLGKKKK | 361 | Q9NVN8 | |
| HIHKLKADKARKKLL | 141 | P84098 | |
| LHKHQRKSIFKIKKK | 706 | Q8WXD0 | |
| QLGSLKKKFKSHHRK | 231 | Q15527 | |
| KKKFKSHHRKPKSFS | 236 | Q15527 | |
| KLRSKIHKKVDRKAS | 496 | Q9NY61 | |
| HLLKRKFGLKSHVSK | 356 | Q9Y2C2 | |
| KAFKHFSALRKHKII | 516 | A8MXY4 | |
| FSALRKHKIIHTGKK | 521 | A8MXY4 | |
| KAFKKKFHFIRHEKN | 166 | Q5T5D7 | |
| KKKSKDKHRDRDSRH | 1201 | Q9H9J4 | |
| EFHALHKKLKKCIKT | 41 | Q9Y343 | |
| KKKHSRKSKRHSSSK | 46 | Q9NXZ1 | |
| KRDSKKEKKHSRSRS | 416 | Q5VTL8 | |
| KRHKIRHTGKKLLKC | 161 | P0DKX0 | |
| TLKHIRHKFFLKKSG | 661 | Q8IZH2 | |
| HRRADKKKRSKLKHR | 1721 | Q9HCK1 | |
| KKKRSKLKHRDLEVS | 1726 | Q9HCK1 | |
| LKTHFRSKDHKKRLK | 76 | O00488 | |
| IEKRKFKSLLLHKRT | 326 | Q9ULQ1 | |
| KHKRFHTREKPFKCK | 451 | Q05481 | |
| LKKKGKDIFHRLHLS | 201 | C9J1S8 | |
| ERKKSSHRGKKSHKR | 401 | Q15695 | |
| KRHSLVHKKDKKYKC | 766 | Q96DT7 | |
| LKKKGKDIFHRLHLS | 201 | A6NDI0 | |
| ATSHLEEKKRKRKKR | 921 | Q9UNX4 | |
| IAFAHKHIKEKRHKK | 256 | Q5VYS8 | |
| LAHKHKKSREVRKSA | 1796 | O75962 | |
| KAFKHFSALRKHKVI | 831 | A6NN14 | |
| HEYWFHKSRRKKKRK | 586 | Q7Z570 |